147 related articles for article (PubMed ID: 24151392)
1. Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer.
Zhang Q; Li K; Xu JH; Zhao CG; Gao Q; Wu B; Liu XY
World J Gastroenterol; 2013 Oct; 19(39):6630-6. PubMed ID: 24151392
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
Kim SH; Kim MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY; Ling H; Lee GW
Am J Clin Oncol; 2015 Jun; 38(3):294-9. PubMed ID: 23689644
[TBL] [Abstract][Full Text] [Related]
3. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
Tian C; Ambrosone CB; Darcy KM; Krivak TC; Armstrong DK; Bookman MA; Davis W; Zhao H; Moysich K; Gallion H; DeLoia JA
Gynecol Oncol; 2012 Mar; 124(3):575-81. PubMed ID: 22112610
[TBL] [Abstract][Full Text] [Related]
4. [Expression of ATP-binding cassette transporter ABCG2 in gastric carcinoma and its significance].
Wang N; Chen L; Wei B; Zhao XY; Lu WJ; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):450-3. PubMed ID: 17851787
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells.
Mosaffa F; Kalalinia F; Lage H; Afshari JT; Behravan J
Mol Cell Biochem; 2012 Apr; 363(1-2):385-93. PubMed ID: 22193459
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
9. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
10. Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.
Zhao J; Li W; Zhu D; Yu Q; Zhang Z; Sun M; Cai S; Zhang W
Med Oncol; 2014 Jan; 31(1):802. PubMed ID: 24338217
[TBL] [Abstract][Full Text] [Related]
11. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
12. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
13. Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.
Li J; Li ZN; Du YJ; Li XQ; Bao QL; Chen P
Clin Lung Cancer; 2009 Nov; 10(6):414-21. PubMed ID: 19900859
[TBL] [Abstract][Full Text] [Related]
14. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma.
Wu Y; Si R; Tang H; He Z; Zhu H; Wang L; Fan Y; Xia S; He Z; Wang Q
Biochem Biophys Res Commun; 2015 Feb; 457(4):614-20. PubMed ID: 25603057
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-328 acts as an anti-oncogene by targeting ABCG2 in gastric carcinoma.
Yan BL; Li XL; An JY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6148-6159. PubMed ID: 31364115
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
18. ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer.
Huang ZH; Hua D; Du X; Li LH; Mao Y; Liu ZH; Song MX; Zhou XK
World J Gastroenterol; 2008 Nov; 14(41):6401-7. PubMed ID: 19009659
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
Tsunoda S; Okumura T; Ito T; Kondo K; Ortiz C; Tanaka E; Watanabe G; Itami A; Sakai Y; Shimada Y
Oncology; 2006; 71(3-4):251-8. PubMed ID: 17671398
[TBL] [Abstract][Full Text] [Related]
20. ABCG2 expression, function, and promoter methylation in human multiple myeloma.
Turner JG; Gump JL; Zhang C; Cook JM; Marchion D; Hazlehurst L; Munster P; Schell MJ; Dalton WS; Sullivan DM
Blood; 2006 Dec; 108(12):3881-9. PubMed ID: 16917002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
